Møller A M, Dalgaard L T, Ambye L, Hansen L, Schmitz O, Hansen T, Pedersen O
Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark.
J Clin Endocrinol Metab. 1999 Jan;84(1):367-9. doi: 10.1210/jcem.84.1.5396.
Mutations in 5 different genes [the hepatocyte nuclear factor (HNF)-4alpha), glucokinase, HNF-1alpha, insulin promoter factor-1, and HNF-1beta genes] have been shown to cause maturity onset diabetes of the young (MODY). About 50% of all known MODY in Danish Caucasian MODY probands can be explained by mutations in the HNF-1alpha gene (MODY3). To estimate the prevalence of MODY caused by mutations in the HNF-4alpha gene (MODY1), we screened 10 non-MODY3 probands for mutations in the minimal promoter and the 12 exons of the HNF-4alpha gene. One of the probands had a novel frameshift mutation (Phe75fsdelT) in exon 2 of the HNF-4alpha gene, resulting in a premature termination of translation after 117 amino acids of the messenger RNA encoded by that allele. The mutation cosegregated with diabetes in the pedigree and was not detected in 84 unrelated Danish Caucasian healthy glucose-tolerant control subjects or in 84 type 2 diabetic patients. At the time of examination, 4 of 6 mutation carriers were treated with insulin and 2 with oral hypoglycemic medication. Two mutation carriers had late-diabetic complications. Even though the HNF-4alpha protein is known to be important in the regulation of genes involved in lipid metabolism, carriers of the mutation did not differ from age and sex-matched control subjects, in regard to levels of fasting serum total cholesterol, serum high-density lipoprotein-cholesterol, and serum triglyceride. In conclusion, by screening 10 non-MODY3 probands for mutations in the HNF-4alpha gene, we identified 1 diabetes-associated frameshift mutation (Phe75fsdelT), suggesting that defects in HNF-4alpha are a rare cause of MODY in Denmark.
已证实5种不同基因(肝细胞核因子(HNF)-4α、葡萄糖激酶、HNF-1α、胰岛素启动子因子-1和HNF-1β基因)的突变可导致青年发病的成年型糖尿病(MODY)。在丹麦白种人MODY先证者中,约50%的已知MODY可由HNF-1α基因(MODY3)的突变来解释。为了估计由HNF-4α基因(MODY1)突变引起的MODY的患病率,我们对10名非MODY3先证者进行了筛查,以寻找HNF-4α基因最小启动子和12个外显子中的突变。其中一名先证者在HNF-4α基因外显子2中有一个新的移码突变(Phe75fsdelT),导致该等位基因编码的信使核糖核酸(mRNA)在117个氨基酸后提前终止翻译。该突变在家族中与糖尿病共分离,在84名无亲缘关系的丹麦白种人糖耐量正常对照者或84名2型糖尿病患者中未检测到。在检查时,6名突变携带者中有4名接受胰岛素治疗,2名接受口服降糖药物治疗。两名突变携带者有晚期糖尿病并发症。尽管已知HNF-4α蛋白在调节参与脂质代谢的基因方面很重要,但就空腹血清总胆固醇、血清高密度脂蛋白胆固醇和血清甘油三酯水平而言,该突变携带者与年龄和性别匹配的对照者并无差异。总之,通过对10名非MODY3先证者进行HNF-4α基因突变筛查,我们鉴定出1个与糖尿病相关的移码突变(Phe75fsdelT),这表明HNF-4α缺陷在丹麦是MODY的罕见病因。